Prospective Breast Cancer Biospecimen Collection
Sponsored by Thomas Jefferson University
About this study
Tissue will be procured during a standard of care procedure the patient will already be scheduled to undergo. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow Up will only consist of chart review to determine date of recurrence, metastases, and/or death
This is a breast cancer biospecimen and possible metastasis procurement study with the goal of obtaining specimens appropriately for genomic and proteomic analysis. Other than reviewing and signing the consent form by the participants in the study, and the study-specific blood tissue procurement and blood draw (and optional biome specimen), all care and clinical encounters will be as per standard of care. There are four times when tissue may be procured and an optional biome specimen collection depending on the treatment course the treating team decides upon. The technique will be chosen based on physician discretion, patient medical treatment, and patient preference. Treatment regimen will consist of tumor sampling/extraction, one blood draw, optional biome specimen collection, and sample…
Where this study is enrolling
- I'm interested
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania
Who can participate
Inclusion criteria
- ✓Adults \>18 years old at time of consent
- ✓Subject must be capable to giving informed consent or have an acceptable surrogate capable of giving consent on the subject behalf.
- ✓Patients with carcinoma in situ or invasive breast cancer
- ✓Patient must be undergoing one of the following:
- ✓definitive surgical tumor resection for breast cancer OR
- ✓placement of a vascular access device as a prelude to neoadjuvant therapy for breast cancer OR
- ✓neurosurgical resection of a brain metastasis from primary breast cancer.
Exclusion criteria
- ✕\<18 years old
- ✕Not able to give informed consent and does not have acceptable surrogate capable to giving informed consent.
- ✕Active drug/alcohol dependence or abuse history
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.